Combination of Ruthenium Complex and Doxorubicin Synergistically Inhibits Cancer Cell Growth by Down-Regulating PI3K/AKT Signaling Pathway
Ke Lin(Wenzhou Medical University), Jinquan Wang(Guangdong Pharmaceutical University)
Cited by 38
Related Papers
Direct cardio-protection of Dapagliflozin against obesity-related cardiomyopathy via NHE1/MAPK signaling
|Acta Pharmacologica Sinica|2022|65
c-Abl Expression in Chronic Lymphocytic Leukemia Cells: Clinical and Therapeutic Implications
|Cancer Research|2006|36